{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:15:16Z","timestamp":1792178116818,"version":"4.4.0"},"reference-count":117,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771521"],"award-info":[{"award-number":["81771521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program","doi-asserted-by":"publisher","award":["2016YFC1306600"],"award-info":[{"award-number":["2016YFC1306600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Guangdong Provincial Key R&D Program","doi-asserted-by":"publisher","award":["2018B030337001"],"award-info":[{"award-number":["2018B030337001"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alzheimer's disease (AD) is the most common form of dementia in the elderly\npopulation and places heavy burdens on medical care and nursing. Recently, the psychiatric and\nbehavioral symptoms of prodromal AD, especially mild behavioral impairment (MBI), have attracted\nmuch attention. In 2012, Alzheimer's Association International Conference, MBI was proposed as a\nsyndrome with psychiatric and behavioral disturbance before the onset of typical clinical cognitive\nsymptoms in dementia. Increasing lines of evidence have indicated the link between MBI and early\nAD pathologies including A\u03b2 and tau.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This narrative review aims to summarize the advantages of MBI over other concept of\npsychiatric and behavioral symptoms associated with AD in the early prediction of AD dementia. We\nalso discuss the possible common genetic basis and pathological mechanisms underlying the interactions\nbetween MBI and AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Papers cited here were retrieved from PubMed up to February 2022. We selected a total of\n95 articles for summary and discussion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The occurrence of MBI is mainly due to the overlapped genetic and pathological risk factors\nwith AD and is related to the brain's response to environmental stressors. MBI may be a warning sign\nfor the early pathology of AD, and more attention should be paid on the number and duration of MBI\nsymptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MBI may be an early sign and predictor of Alzheimer's disease dementia. Early intervention\nfor MBI may have a positive effect on alleviating long-term cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1567205019666220805114528","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T07:56:37Z","timestamp":1659686197000},"page":"407-419","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's\nDisease Dementia"],"prefix":"10.2174","volume":"19","author":[{"given":"Fei","family":"Jiang","sequence":"first","affiliation":[{"name":"Clinical Research Center for Psychiatry, Dalian Seventh Peolpe\\'s Hospital, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Liaoning Provincial\nKey Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital,\nDalian Medical University, Dalian 116021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Huang","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Psychiatry, Dalian Seventh Peolpe\\'s Hospital, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Psychiatry, Dalian Seventh Peolpe\\'s Hospital, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[{"name":"Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian 116021, China;"},{"name":"Institute of Neurology, Sichuan Academy of Medical Sciences,\nSichuan Provincial Hospital, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S654","DOI":"10.1016\/j.eurpsy.2017.01.1097","volume":"41","author":"Jmi G.","year":"2020","unstructured":"Jmi G.; Robbana L.; Ghali F.; The burden of caregivers of patients with alzheimer. Eur Psychiatry 2020,41(S1),S654-S54","journal-title":"Eur Psychiatry"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1212\/NXG.0000000000000516","volume":"6","author":"Linden D.E.J.","year":"2020","unstructured":"Linden D.E.J.; Genetic risk for Alzheimer disease affects the brain throughout the lifespan. Neurol Genet 2020,6(5),e516","journal-title":"Neurol Genet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E9338","DOI":"10.3390\/ijms21249338","volume":"21","author":"T\u00f6r\u00f6k N.","year":"2020","unstructured":"T\u00f6r\u00f6k N.; Tanaka M.; V\u00e9csei L.; Searching for peripheral biomarkers in neurodegenerative diseases: The tryptophan-kynurenine metabolic pathway. Int J Mol Sci 2020,21(24),E9338","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"12592","DOI":"10.1038\/s41598-018-31000-9","volume":"8","author":"Battaglia S.","year":"2018","unstructured":"Battaglia S.; Garofalo S.; di Pellegrino G.; Context-dependent extinction of threat memories: Influences of healthy aging. Sci Rep 2018,8(1),12592","journal-title":"Sci Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3233\/JAD-180700","volume":"66","author":"Eikelboom W.S.","year":"2018","unstructured":"Eikelboom W.S.; van Rooij J.G.J.; van den Berg E.; Neuropsychiatric symptoms complicating the diagnosis of alzheimer\u2019s disease: A case report. J Alzheimers Dis 2018,66(4),1363-1369","journal-title":"J Alzheimers Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S1041610217001855","volume":"30","author":"Cieslak A.","year":"2018","unstructured":"Cieslak A.; Smith E.E.; Lysack J.; Ismail Z.; Case series of mild behavioral impairment: Toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition. Int Psychogeriatr 2018,30(2),273-280","journal-title":"Int Psychogeriatr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e100283","DOI":"10.1136\/gpsych-2020-100283","volume":"34","author":"Zhu L.","year":"2021","unstructured":"Zhu L.; Sun L.; Sun L.; Xiao S.; Case of early-onset Alzheimer\u2019s disease with atypical manifestation. Gen Psychiatr 2021,34(1),e100283","journal-title":"Gen Psychiatr"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.psc.2015.01.009","volume":"38","author":"Su\u00e1rez G.A.","year":"2015","unstructured":"Su\u00e1rez G.A.; Henley S.M.; Walton J.; Crutch S.J.; Posterior cortical atrophy: An atypical variant of Alzheimer disease. Psychiatr Clin North Am 2015,38(2),211-220","journal-title":"Psychiatr Clin North Am"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ana.26071","volume":"89","author":"Petersen R.C.","year":"2021","unstructured":"Petersen R.C.; Wiste H.J.; Weigand S.D.; NIA-AA alzheimer\u2019s disease framework: Clinical characterization of stages. Ann Neurol 2021,89(6),1145-1156","journal-title":"Ann Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/biomedicines10030627","volume":"10","author":"Battaglia S.","year":"2022","unstructured":"Battaglia S.; Fabius J.H.; Moravkova K.; Fracasso A.; Borgomaneri S.; The neurobiological correlates of gaze perception in healthy individuals and neurologic patients. Biomedicines 2022,10(3),627","journal-title":"Biomedicines"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4088\/JCP.08m04181","volume":"70","author":"Taragano F.E.","year":"2009","unstructured":"Taragano F.E.; Allegri R.F.; Krupitzki H.; Mild behavioral impairment and risk of dementia: A prospective cohort study of 358 patients. J Clin Psychiatry 2009,70(4),584-592","journal-title":"J Clin Psychiatry"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF03075177","volume":"31","author":"Carla S.D.","year":"2006","unstructured":"Carla S.D.; Mild Behavioral Impairment. Tijdschrift voor VerpleeghuisGeneeskunde 2006,31(4),152-156","journal-title":"Tijdschrift voor VerpleeghuisGeneeskunde"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1590\/S1980-57642009DN20400004","volume":"2","author":"Taragano F.E.","year":"2008","unstructured":"Taragano F.E.; Allegri R.F.; Lyketsos C.; Mild behavioral impairment: A prodromal stage of dementia. Dement Neuropsychol 2008,2(4),256-260","journal-title":"Dement Neuropsychol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jagp.2019.01.215","volume":"27","author":"Creese B.","year":"2019","unstructured":"Creese B.; Brooker H.; Ismail Z.; Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry 2019,27(8),823-834","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13195-020-00701-7","volume":"12","author":"Sannemann L.","year":"2020","unstructured":"Sannemann L.; Schild A.K.; Altenstein S.; Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study. Alzheimers Res Ther 2020,12(1),131","journal-title":"Alzheimers Res Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","volume":"11","author":"Johansson M.","year":"2021","unstructured":"Johansson M.; Stomrud E.; Insel P.S.; Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer\u2019s disease. Transl Psychiatry 2021,11(1),76","journal-title":"Transl Psychiatry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3233\/JAD-160979","volume":"56","author":"Ismail Z.","year":"2017","unstructured":"Ismail Z.; Ag\u00fcera O.L.; Brodaty H.; The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis 2017,56(3),929-938","journal-title":"J Alzheimers Dis"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.047673","volume":"16","author":"Kassam F.","year":"2020","unstructured":"Kassam F.; Chen H.Y.; Nosheny R.L.; Cognitive profile of mild behavioral impairment (MBI) in brain health registry participants. Alzheimers Dement 2020,16(S6)","journal-title":"Alzheimers Dement"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.039239","volume":"16","author":"Soo S.A.","year":"2020","unstructured":"Soo S.A.; Ng K.P.; Wong F.; Mild behaviour impairment checklist (MBI\u2010C): Is there a difference in ratings between patient and close informant? Alzheimers Dement 2020,16(S6)","journal-title":"Alzheimers Dement"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/s41380-021-01152-8","volume":"26","author":"DeMichele-Sweet M.A.A.","year":"2021","unstructured":"DeMichele-Sweet M.A.A.; Klei L.; Creese B.; Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry 2021,26(10),5797-5811","journal-title":"Mol Psychiatry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"E90","DOI":"10.3390\/jpm10030090","volume":"10","author":"Scassellati C.","year":"2020","unstructured":"Scassellati C.; Ciani M.; Maj C.; Behavioral and Psychological Symptoms of Dementia (BPSD): Clinical characterization and genetic correlates in an Italian Alzheimer\u2019s disease cohort. J Pers Med 2020,10(3),E90","journal-title":"J Pers Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"Harold D.","year":"2009","unstructured":"Harold D.; Abraham R.; Hollingworth P.; Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 2009,41(10),1088-1093","journal-title":"Nat Genet"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000497164","volume":"78","author":"Porcelli S.","year":"2019","unstructured":"Porcelli S.; Calabr\u00f2 M.; Crisafulli C.; Alzheimer\u2019s disease and neurotransmission gene variants: Focus on their effects on psychiatric comorbidities and inflammatory parameters. Neuropsychobiology 2019,78(2),79-85","journal-title":"Neuropsychobiology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ajmg.b.32684","volume":"177","author":"Andrews S.J.","year":"2018","unstructured":"Andrews S.J.; Ismail Z.; Anstey K.J.; Mortby M.; Association of Alzheimer\u2019s genetic loci with mild behavioral impairment. Am J Med Genet B Neuropsychiatr Genet 2018,177(8),727-735","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"Naj A.C.","year":"2011","unstructured":"Naj A.C.; Jun G.; Beecham G.W.; Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 2011,43(5),436-441","journal-title":"Nat Genet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-150181","volume":"49","author":"Bensamoun D.","year":"2016","unstructured":"Bensamoun D.; Guignard R.; Furst A.J.; Associations between neuropsychiatric symptoms and cerebral amyloid deposition in cognitively impaired elderly people. J Alzheimers Dis 2016,49(2),387-398","journal-title":"J Alzheimers Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/jnnp-2013-306110","volume":"85","author":"Mori T.","year":"2014","unstructured":"Mori T.; Shimada H.; Shinotoh H.; Apathy correlates with prefrontal amyloid \u03b2 deposition in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2014,85(4),449-455","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1041610217002368","volume":"30","author":"Krell R.J.","year":"2018","unstructured":"Krell R.J.; Lowe V.J.; Neureiter J.; Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: The mayo clinic study of aging. Int Psychogeriatr 2018,30(2),245-251","journal-title":"Int Psychogeriatr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3233\/JAD-170067","volume":"58","author":"Babulal G.M.","year":"2017","unstructured":"Babulal G.M.; Stout S.H.; Head D.; Neuropsychiatric symptoms and alzheimer\u2019s disease biomarkers predict driving decline: Brief report. J Alzheimers Dis 2017,58(3),675-680","journal-title":"J Alzheimers Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000363500","volume":"4","author":"Bloniecki V.","year":"2014","unstructured":"Bloniecki V.; Aarsland D.; Cummings J.; Blennow K.; Freund L.Y.; Agitation in dementia: Relation to core cerebrospinal fluid biomarker levels. Dement Geriatr Cogn Disord Extra 2014,4(2),335-343","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Heneka M.T.","year":"2015","unstructured":"Heneka M.T.; Carson M.J.; El Khoury J.; Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 2015,14(4),388-405","journal-title":"Lancet Neurol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"Ising C.","year":"2019","unstructured":"Ising C.; Venegas C.; Zhang S.; NLRP3 inflammasome activation drives tau pathology. Nature 2019,575(7784),669-673","journal-title":"Nature"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"Maphis N.","year":"2015","unstructured":"Maphis N.; Xu G.; Kokiko C.O.N.; Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 2015,138(Pt 6),1738-1755","journal-title":"Brain"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2016.09.053","volume":"370","author":"Porcelli S.","year":"2016","unstructured":"Porcelli S.; Crisafulli C.; Donato L.; Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer\u2019s disease. J Neurol Sci 2016,370,162-166","journal-title":"J Neurol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.tips.2017.07.005","volume":"38","author":"Cuello A.C.","year":"2017","unstructured":"Cuello A.C.; Early and Late CNS Inflammation in Alzheimer\u2019s Disease: Two Extremes of a Continuum? Trends Pharmacol Sci 2017,38(11),956-966","journal-title":"Trends Pharmacol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"Pascoal T.A.","year":"2021","unstructured":"Pascoal T.A.; Benedet A.L.; Ashton N.J.; Microglial activation and tau propagate jointly across Braak stages. Nat Med 2021,27(9),1592-1599","journal-title":"Nat Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.nbd.2018.06.004","volume":"117","author":"Parbo P.","year":"2018","unstructured":"Parbo P.; Ismail R.; Sommerauer M.; Does inflammation precede tau aggregation in early Alzheimer\u2019s disease? A PET study. Neurobiol Dis 2018,117,211-216","journal-title":"Neurobiol Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","volume":"44","author":"M\u00fcller N.","year":"2018","unstructured":"M\u00fcller N.; Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull 2018,44(5),973-982","journal-title":"Schizophr Bull"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fpsyt.2020.00549","volume":"11","author":"Severance E.G.","year":"2020","unstructured":"Severance E.G.; Dickerson F.; Yolken R.H.; Complex gastrointestinal and Endocrine Sources of Inflammation in Schizophrenia. Front Psychiatry 2020,11,549","journal-title":"Front Psychiatry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2018_88","volume":"44","author":"Upthegrove R.","year":"2020","unstructured":"Upthegrove R.; Khandaker G.M.; Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci 2020,44,49-66","journal-title":"Curr Top Behav Neurosci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2174\/1570159X14666160106155331","volume":"14","author":"Sharma A.","year":"2016","unstructured":"Sharma A.; Systems genomics support for immune and inflammation hypothesis of depression. Curr Neuropharmacol 2016,14(7),749-758","journal-title":"Curr Neuropharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"E1905","DOI":"10.3390\/ijms20081905","volume":"20","author":"Yao H.","year":"2019","unstructured":"Yao H.; Mizoguchi Y.; Monji A.; Low-grade inflammation is associated with apathy indirectly via deep white matter lesions in community-dwelling older adults: The sefuri study. Int J Mol Sci 2019,20(8),E1905","journal-title":"Int J Mol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","volume":"84","author":"Masters M.C.","year":"2015","unstructured":"Masters M.C.; Morris J.C.; Roe C.M.; \u201cNoncognitive\u201d symptoms of early Alzheimer disease: A longitudinal analysis. Neurology 2015,84(6),617-622","journal-title":"Neurology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","volume":"36","author":"Ledo J.H.","year":"2016","unstructured":"Ledo J.H.; Azevedo E.P.; Beckman D.; Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by alzheimer\u2019s amyloid-\u03b2 oligomers in mice. J Neurosci 2016,36(48),12106-12116","journal-title":"J Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbi.2016.01.003","volume":"57","author":"Lasselin J.","year":"2016","unstructured":"Lasselin J.; Elsenbruch S.; Lekander M.; Mood disturbance during experimental endotoxemia: Predictors of state anxiety as a psychological component of sickness behavior. Brain Behav Immun 2016,57,30-37","journal-title":"Brain Behav Immun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","volume":"77","author":"Holmes C.","year":"2011","unstructured":"Holmes C.; Cunningham C.; Zotova E.; Culliford D.; Perry V.H.; Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 2011,77(3),212-218","journal-title":"Neurology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-021-00456-1","volume":"16","author":"Chen Y.","year":"2021","unstructured":"Chen Y.; Dang M.; Zhang Z.; Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer\u2019s disease: A systematic review of symptom-general and-specific lesion patterns. Mol Neurodegener 2021,16(1),38","journal-title":"Mol Neurodegener"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-190496","volume":"73","author":"Albaret G.","year":"2020","unstructured":"Albaret G.; Sifr\u00e9 E.; Floch P.; Alzheimer\u2019s disease and helicobacter pylori infection: Inflammation from stomach to brain? J Alzheimers Dis 2020,73(2),801-809","journal-title":"J Alzheimers Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.csbj.2019.09.008","volume":"17","author":"Lin C.","year":"2019","unstructured":"Lin C.; Zhao S.; Zhu Y.; Microbiota-gut-brain axis and toll-like receptors in Alzheimer\u2019s disease. Comput Struct Biotechnol J 2019,17,1309-1317","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3389\/fimmu.2017.01613","volume":"8","author":"Holzer P.","year":"2017","unstructured":"Holzer P.; Farzi A.; Hassan A.M.; Zenz G.; Ja\u010dan A.; Reichmann F.; Visceral inflammation and immune activation stress the brain. Front Immunol 2017,8,1613","journal-title":"Front Immunol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biopsych.2017.11.005","volume":"83","author":"Dinan T.G.","year":"2018","unstructured":"Dinan T.G.; Cryan J.F.; Stanton C.; Gut microbes and brain development have black box connectivity. Biol Psychiatry 2018,83(2),97-99","journal-title":"Biol Psychiatry"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/gbb.12109","volume":"13","author":"Stilling R.M.","year":"2014","unstructured":"Stilling R.M.; Dinan T.G.; Cryan J.F.; Microbial genes, brain","journal-title":"Genes Brain Behav"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41564-021-00904-0","volume":"6","author":"Kennedy K.M.","year":"2021","unstructured":"Kennedy K.M.; Gerlach M.J.; Adam T.; Fetal meconium does not have a detectable microbiota before birth. Nat Microbiol 2021,6(7),865-873","journal-title":"Nat Microbiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"20858","DOI":"10.1038\/srep20858","volume":"6","author":"Ting S.K.","year":"2016","unstructured":"Ting S.K.; Hao Y.; Chia P.S.; Tan E.K.; Hameed S.; Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer\u2019s disease. Sci Rep 2016,6(1),20858","journal-title":"Sci Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-150606","volume":"50","author":"Fischer C.E.","year":"2016","unstructured":"Fischer C.E.; Qian W.; Schweizer T.A.; Lewy bodies, vascular risk factors, and subcortical arteriosclerotic leukoencephalopathy, but not alzheimer pathology, are associated with development of psychosis in alzheimer\u2019s disease. J Alzheimers Dis 2016,50(1),283-295","journal-title":"J Alzheimers Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/gps.3980","volume":"29","author":"Steinberg M.","year":"2014","unstructured":"Steinberg M.; Hess K.; Corcoran C.; Vascular risk factors and neuropsychiatric symptoms in Alzheimer\u2019s disease: The Cache County Study. Int J Geriatr Psychiatry 2014,29(2),153-159","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3233\/JAD-160506","volume":"55","author":"Kim J.","year":"2017","unstructured":"Kim J.; Schweizer T.A.; Fischer C.E.; Munoz D.G.; The role of cerebrovascular disease on cognitive and functional status and psychosis in severe alzheimer\u2019s disease. J Alzheimers Dis 2017,55(1),381-389","journal-title":"J Alzheimers Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/gps.4693","volume":"33","author":"Yatawara C.","year":"2018","unstructured":"Yatawara C.; Hiu S.; Tan L.; Kandiah N.; Neuropsychiatric symptoms in South-East Asian patients with mild cognitive impairment and dementia: Prevalence, subtypes, and risk factors. Int J Geriatr Psychiatry 2018,33(1),122-130","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/ijms.60810","volume":"18","author":"Shu J.","year":"2021","unstructured":"Shu J.; Qiang Q.; Yan Y.; Distinct patterns of brain atrophy associated with mild behavioral impairment in cognitively normal elderly adults. Int J Med Sci 2021,18(13),2950-2956","journal-title":"Int J Med Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"643271","DOI":"10.3389\/fnagi.2021.643271","volume":"13","author":"Matuskova V.","year":"2021","unstructured":"Matuskova V.; Ismail Z.; Nikolai T.; Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort. Front Aging Neurosci 2021,13,643271","journal-title":"Front Aging Neurosci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.nicl.2020.102367","volume":"28","author":"Misquitta K.","year":"2020","unstructured":"Misquitta K.; Dadar M.; Louis Collins D.; Tartaglia M.C.; White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer\u2019s disease. Neuroimage Clin 2020,28,102367","journal-title":"Neuroimage Clin"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12888-020-02537-9","volume":"20","author":"Li X.","year":"2020","unstructured":"Li X.; Xiong Z.; Liu Y.; Case report of first-episode psychotic symptoms in a patient with early-onset Alzheimer\u2019s disease. BMC Psychiatry 2020,20(1),128","journal-title":"BMC Psychiatry"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/gps.5540","volume":"36","author":"Gill S.","year":"2021","unstructured":"Gill S.; Wang M.; Mouches P.; Neural correlates of the impulse dyscontrol domain of mild behavioral impairment. Int J Geriatr Psychiatry 2021,36(9),1398-1406","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"595758","DOI":"10.3389\/fnagi.2021.595758","volume":"13","author":"Cotta Ramusino M.","year":"2021","unstructured":"Cotta Ramusino M.; Perini G.; Vaghi G.; Correlation of frontal atrophy and csf tau levels with neuropsychiatric symptoms in patients with cognitive impairment: A memory clinic experience. Front Aging Neurosci 2021,13,595758","journal-title":"Front Aging Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1192\/bjp.163.3.364","volume":"163","author":"F\u00f6rstl H.","year":"1993","unstructured":"F\u00f6rstl H.; Burns A.; Levy R.; Cairns N.; Luthert P.; Lantos P.; Neuropathological correlates of behavioural disturbance in confirmed Alzheimer\u2019s disease. Br J Psychiatry 1993,163(3),364-368","journal-title":"Br J Psychiatry"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/JAD-170632","volume":"62","author":"Taragano F.E.","year":"2018","unstructured":"Taragano F.E.; Allegri R.F.; Heisecke S.L.; Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis 2018,62(1),227-238","journal-title":"J Alzheimers Dis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-190025","volume":"70","author":"Dietlin S.","year":"2019","unstructured":"Dietlin S.; Soto M.; Kiyasova V.; Neuropsychiatric symptoms and risk of progression to Alzheimer\u2019s disease among mild cognitive impairment subjects. J Alzheimers Dis 2019,70(1),25-34","journal-title":"J Alzheimers Dis"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1002\/alz.041963","volume":"16","author":"Mallo S.C.","year":"2020","unstructured":"Mallo S.C.; Pereiro A.X.; Campos\u2010Magdaleno M.; Neuropsy-chiatric symptoms in subjective cognitive complaints (SCC) and mild cognitive impairment (MCI): Detecting changes over time with the Mild Behavioral Impairment Checklist (MBI\u2010C). Alzheimers Dement 2020,16(S6)","journal-title":"Alzheimers Dement"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/jnu.12692","volume":"53","author":"Ahn S.","year":"2021","unstructured":"Ahn S.; Mathiason M.A.; Yu F.; Longitudinal cognitive profiles by anxiety and depressive symptoms in american older adults with subjective cognitive decline. J Nurs Scholarsh 2021,53(6),698-708","journal-title":"J Nurs Scholarsh"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuropsychologia.2018.01.039","volume":"118","author":"Perri R","year":"2018","unstructured":"Perri R; Turchetta CS; Caruso G; Fadda L; Caltagirone C; Carlesimo GA; Neuropsychological correlates of cognitive, emotional-affective and auto-activation apathy in Alzheimer's disease. Neuropsychologia 2018,118(B),12-21","journal-title":"Neuropsychologia"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12888-021-03210-5","volume":"21","author":"Shao Y.","year":"2021","unstructured":"Shao Y.; Xu H.; Wang J.; Agitation and apathy increase risk of dementia in psychiatric inpatients with late-onset psychiatric symptoms. BMC Psychiatry 2021,21(1),214","journal-title":"BMC Psychiatry"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1176\/appi.ajp.2014.13060821","volume":"171","author":"Geda Y.E.","year":"2014","unstructured":"Geda Y.E.; Roberts R.O.; Mielke M.M.; Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. Am J Psychiatry 2014,171(5),572-581","journal-title":"Am J Psychiatry"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jalz.2017.08.015","volume":"14","author":"Acosta I.","year":"2018","unstructured":"Acosta I.; Borges G.; Aguirre-Hernandez R.; Sosa A.L.; Prince M.; Neuropsychiatric symptoms as risk factors of dementia in a Mexican population: A 10\/66 Dementia Research Group study. Alzheimers Dement 2018,14(3),271-279","journal-title":"Alzheimers Dement"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/gps.2187","volume":"24","author":"Edwards E.R.","year":"2009","unstructured":"Edwards E.R.; Spira A.P.; Barnes D.E.; Yaffe K.; Neuropsychiatric symptoms in mild cognitive impairment: Differences by subtype and progression to dementia. Int J Geriatr Psychiatry 2009,24(7),716-722","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neubiorev.2016.08.025","volume":"69","author":"Canevelli M.","year":"2016","unstructured":"Canevelli M.; Blasimme A.; Vanacore N.; Bruno G.; Cesari M.; Mild behavioral impairment: Ethical, methodological and clinical reflections. Neurosci Biobehav Rev 2016,69,402-403","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000507286","volume":"49","author":"Reisberg B.","year":"2020","unstructured":"Reisberg B.; Shao Y.; Moosavi M.; Psychometric cognitive decline precedes the advent of subjective cognitive decline in the evolution of alzheimer\u2019s disease. Dement Geriatr Cogn Disord 2020,49(1),16-21","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1212\/WNL.0000000000010142","volume":"95","author":"Wolfsgruber S.","year":"2020","unstructured":"Wolfsgruber S.; Kleineidam L.; Guski J.; Minor neuropsychological deficits in patients with subjective cognitive decline. Neurology 2020,95(9),e1134-e1143","journal-title":"Neurology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/psyg.12636","volume":"21","author":"Pan Y.","year":"2021","unstructured":"Pan Y.; Shea Y.F.; Li S.; Prevalence of mild behavioural impairment: A systematic review and meta-analysis. Psychogeriatrics 2021,21(1),100-111","journal-title":"Psychogeriatrics"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1017\/S104161021700151X","volume":"30","author":"Sheikh F.","year":"2018","unstructured":"Sheikh F.; Ismail Z.; Mortby M.E.; Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr 2018,30(2),233-244","journal-title":"Int Psychogeriatr"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-201184","volume":"80","author":"Ismail Z.","year":"2021","unstructured":"Ismail Z.; McGirr A.; Gill S.; Hu S.; Forkert N.D.; Smith E.E.; Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline. J Alzheimers Dis 2021,80(1),459-469","journal-title":"J Alzheimers Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1590\/S1980-57642013DN70300002","volume":"7","author":"Tascone L.D.S.","year":"2013","unstructured":"Tascone L.D.S.; Bottino C.M.C.; Neurobiology of neuropsychiatric symptoms in Alzheimer\u2019s disease: A critical review with a focus on neuroimaging. Dement Neuropsychol 2013,7(3),236-243","journal-title":"Dement Neuropsychol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13195-020-00756-6","volume":"13","author":"Cicognola C.","year":"2021","unstructured":"Cicognola C.; Hansson O.; Scheltens P.; Cerebrospinal fluid N-224 tau helps discriminate Alzheimer\u2019s disease from subjective cognitive decline and other dementias. Alzheimers Res Ther 2021,13(1),38","journal-title":"Alzheimers Res Ther"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"Karran E.","year":"2011","unstructured":"Karran E.; Mercken M.; De Strooper B.; The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics. Nat Rev Drug Discov 2011,10(9),698-712","journal-title":"Nat Rev Drug Discov"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-200011","volume":"76","author":"Naude J.P.","year":"2020","unstructured":"Naude J.P.; Gill S.; Hu S.; Plasma neurofilament light: A marker of neurodegeneration in mild behavioral impairment. J Alzheimers Dis 2020,76(3),1017-1027","journal-title":"J Alzheimers Dis"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/S1041610219001030","volume":"32","author":"Mallo S.C.","year":"2020","unstructured":"Mallo S.C.; Valladares R.S.; Facal D.; Lojo S.C.; Fern\u00e1ndez I.M.J.; Pereiro A.X.; Neuropsychiatric symptoms as predictors of conversion from MCI to dementia: A machine learning approach. Int Psychogeriatr 2020,32(3),381-392","journal-title":"Int Psychogeriatr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1148\/radiol.2018171820","volume":"288","author":"Choy G.","year":"2018","unstructured":"Choy G.; Khalilzadeh O.; Michalski M.; Current applications and future impact of machine learning in radiology. Radiology 2018,288(2),318-328","journal-title":"Radiology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacr.2017.12.028","volume":"15(3)","author":"Giger ML","year":"2018","unstructured":"Giger ML; Machine learning in medical imaging J Am Coll Radiol 2018,15(3)(Pt B),512-520","journal-title":"J Am Coll Radiol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"LeCun Y.","year":"2015","unstructured":"LeCun Y.; Bengio Y.; Hinton G.; Deep learning. Nature 2015,521(7553),436-444","journal-title":"Nature"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1038\/s41598-019-49656-2","volume":"9","author":"Fisher C.K.","year":"2019","unstructured":"Fisher C.K.; Smith A.M.; Walsh J.R.; Coalition Against Major D.; Machine learning for comprehensive forecasting of Alzheimer\u2019s Disease progression. Sci Rep 2019,9(1),13622","journal-title":"Sci Rep"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/ETLS20210249","volume":"5","author":"Li Z.","year":"2021","unstructured":"Li Z.; Jiang X.; Wang Y.; Kim Y.; Applied machine learning in Alzheimer\u2019s disease research: Omics, imaging, and clinical data. Emerg Top Life Sci 2021,5(6),765-777","journal-title":"Emerg Top Life Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1038\/s41598-018-22871-z","volume":"8","author":"Lu D.","year":"2018","unstructured":"Lu D.; Popuri K.; Ding G.W.; Balachandar R.; Beg M.F.; Multimodal and multiscale deep neural networks for the early diagnosis of alzheimer\u2019s disease using structural MR and FDG-PET images. Sci Rep 2018,8(1),5697","journal-title":"Sci Rep"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuroimage.2012.04.056","volume":"62","author":"Westman E.","year":"2012","unstructured":"Westman E.; Muehlboeck J.S.; Simmons A.; Combining MRI and CSF measures for classification of Alzheimer\u2019s disease and prediction of mild cognitive impairment conversion. Neuroimage 2012,62(1),229-238","journal-title":"Neuroimage"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuroimage.2019.01.031","volume":"189","author":"Spasov S.","year":"2019","unstructured":"Spasov S.; Passamonti L.; Duggento A.; Li\u00f2 P.; Toschi N.; A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer\u2019s disease. Neuroimage 2019,189,276-287","journal-title":"Neuroimage"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jalz.2019.06.3935","volume":"15","author":"Gill S.","year":"2019","unstructured":"Gill S.; Mouches P.; Wang M.; P4-266: Using machine learning to identify neuroimaging and clinical features of Mild Behavioral Impairment (Mbi). Alzheimers Dement 2019,15,1383-P83","journal-title":"Alzheimers Dement"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-191169","volume":"75","author":"Gill S.","year":"2020","unstructured":"Gill S.; Mouches P.; Hu S.; Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data. J Alzheimers Dis 2020,75(1),277-288","journal-title":"J Alzheimers Dis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"S443","DOI":"10.1016\/S0924-977X(12)70697-1","volume":"22","author":"Kasper S.","year":"2012","unstructured":"Kasper S.; Targeting cognitive and neuropsychiatric symptoms in early dementia. Eur Neuropsychopharmacol 2012,22(1),S443","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jagp.2020.04.026","volume":"29","author":"Dyck C.H.","year":"2021","unstructured":"Dyck C.H.; Arnsten A.F.T.; Padala P.R.; Neurobiologic rationale for treatment of apathy in alzheimer\u2019s disease with methylphenidate. Am J Geriatr Psychiatry 2021,29(1),51-62","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/JGP.0b013e31822001a6","volume":"20","author":"Berman K.","year":"2012","unstructured":"Berman K.; Brodaty H.; Withall A.; Seeher K.; Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry 2012,20(2),104-122","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0891988716678684","volume":"30","author":"Theleritis C.","year":"2017","unstructured":"Theleritis C.; Siarkos K.; Katirtzoglou E.; Politis A.; Pharmacological and nonpharmacological treatment for apathy in alzheimer disease: A systematic review across modalities. J Geriatr Psychiatry Neurol 2017,30(1),26-49","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jagp.2021.06.016","volume":"30","author":"Mortby M.E.","year":"2021","unstructured":"Mortby M.E.; Adler L.; Aguera O.L.; Bateman D.R.; Brodaty H.; Cantillon M.; Apathy as a treatment target in Alzheimer\u2019s disease: Implications for clinical trials. Am J Geriatr Psychiatry 2021,30(2),119-147","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1017\/S1041610200006633","volume":"12","author":"Negr\u00f3n A.E.","year":"2000","unstructured":"Negr\u00f3n A.E.; Reichman W.E.; Risperidone in the treatment of patients with Alzheimer\u2019s disease with negative symptoms. Int Psychogeriatr 2000,12(4),527-536","journal-title":"Int Psychogeriatr"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.schres.2005.06.001","volume":"78","author":"Dollfus S.","year":"2005","unstructured":"Dollfus S.; Olivier V.; Chabot B.; D\u00e9al C.; Perrin E.; Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients. Schizophr Res 2005,78(2-3),157-159","journal-title":"Schizophr Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pnpbp.2006.09.001","volume":"31","author":"Onor M.L.","year":"2007","unstructured":"Onor M.L.; Saina M.; Trevisiol M.; Cristante T.; Aguglia E.; Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 2007,31(1),205-209","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jad.2020.05.150","volume":"274","author":"Chan Y.E.","year":"2020","unstructured":"Chan Y.E.; Chen M.H.; Tsai S.J.; Treatment-Resistant depression enhances risks of dementia and alzheimer\u2019s disease: A nationwide longitudinal study. J Affect Disord 2020,274,806-812","journal-title":"J Affect Disord"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14283\/jpad.2019.24","volume":"6","author":"Cumbo E.","year":"2019","unstructured":"Cumbo E.; Cumbo S.; Torregrossa S.; Migliore D.; Treatment effects of vortioxetine on cognitive functions in mild Alzheimer\u2019s disease patients with depressive symptoms: A 12 month, open-label, observational study. J Prev Alzheimers Dis 2019,6(3),192-197","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","volume":"95","author":"Cirrito J.R.","year":"2020","unstructured":"Cirrito J.R.; Wallace C.E.; Yan P.; Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model. Neurology 2020,95(19),e2666-e2674","journal-title":"Neurology"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"Cirrito J.R.","year":"2011","unstructured":"Cirrito J.R.; Disabato B.M.; Restivo J.L.; Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans. Proc Natl Acad Sci USA 2011,108(36),14968-14973","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"113525","DOI":"10.1016\/j.physbeh.2021.113525","volume":"239","author":"Ilieva K.","year":"2021","unstructured":"Ilieva K.; Atanasova M.; Atanasova D.; Kortenska L.; Tchekalarova J.; Chronic agomelatine treatment alleviates icvA\u03b2-induced anxiety and depressive-like behavior through affecting A\u03b2 metabolism in the hippocampus in a rat model of Alzheimer\u2019s disease. Physiol Behav 2021,239,113525","journal-title":"Physiol Behav"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/glia.22926","volume":"64","author":"Qiao J.","year":"2016","unstructured":"Qiao J.; Wang J.; Wang H.; Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP\/PS1 mouse model. Glia 2016,64(2),240-254","journal-title":"Glia"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1567205011666140812114715","volume":"11","author":"Wang J.","year":"2014","unstructured":"Wang J.; Zhang Y.; Xu H.; Fluoxetine improves behavioral performance by suppressing the production of soluble \u03b2-amyloid in APP\/PS1 mice. Curr Alzheimer Res 2014,11(7),672-680","journal-title":"Curr Alzheimer Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"Mattson M.P.","year":"2004","unstructured":"Mattson M.P.; Pathways towards and away from Alzheimer\u2019s disease. Nature 2004,430(7000),631-639","journal-title":"Nature"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"e12030","DOI":"10.1002\/trc2.12030","volume":"6","author":"Chen J.","year":"2020","unstructured":"Chen J.; Zhang F.; Zhao L.; Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer\u2019s disease and amnestic mild cognitive impairment. Alzheimers Dement (N Y) 2020,6(1),e12030","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.psychres.2017.12.063","volume":"261","author":"Padala P.R.","year":"2018","unstructured":"Padala P.R.; Padala K.P.; Lensing S.Y.; Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: A double-blind, randomized, sham-controlled, cross-over pilot study. Psychiatry Res 2018,261,312-318","journal-title":"Psychiatry Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/alz.12258","volume":"17","author":"Li S.","year":"2021","unstructured":"Li S.; Wu Z.; Le W.; Traditional Chinese medicine for dementia. Alzheimers Dement 2021,17(6),1066-1071","journal-title":"Alzheimers Dement"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fneur.2019.01059","volume":"10","author":"Cajanus A.","year":"2019","unstructured":"Cajanus A.; Solje E.; Koikkalainen J.; The association between distinct frontal brain volumes and behavioral symptoms in mild cognitive impairment, Alzheimer\u2019s disease, and frontotemporal dementia. Front Neurol 2019,10,1059","journal-title":"Front Neurol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41380-021-01326-4","volume":"27","author":"Battaglia S.","year":"2022","unstructured":"Battaglia S.; Harrison B.J.; Fullana M.A.; Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions. Mol Psychiatry 2022,27(2),784-786","journal-title":"Mol Psychiatry"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"217","DOI":"10.17219\/acem\/146756","volume":"31","author":"Battaglia S.","year":"2022","unstructured":"Battaglia S.; Neurobiological advances of learned fear in humans. Adv Clin Exp Med 2022,31(3),217","journal-title":"Adv Clin Exp Med"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220805114528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207311\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220805114528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:29:12Z","timestamp":1691774952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207311\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205019666220805114528","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}